BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shcharbin D, Janaszewska A, Klajnert-maculewicz B, Ziemba B, Dzmitruk V, Halets I, Loznikova S, Shcharbina N, Milowska K, Ionov M, Shakhbazau A, Bryszewska M. How to study dendrimers and dendriplexes III. Biodistribution, pharmacokinetics and toxicity in vivo. Journal of Controlled Release 2014;181:40-52. [DOI: 10.1016/j.jconrel.2014.02.021] [Cited by in Crossref: 68] [Cited by in F6Publishing: 61] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Mignani S, Shi X, Rodrigues J, Tomas H, Karpus A, Majoral J. First-in-class and best-in-class dendrimer nanoplatforms from concept to clinic: Lessons learned moving forward. European Journal of Medicinal Chemistry 2021;219:113456. [DOI: 10.1016/j.ejmech.2021.113456] [Reference Citation Analysis]
2 Ma Y, Mou Q, Wang D, Zhu X, Yan D. Dendritic Polymers for Theranostics. Theranostics 2016;6:930-47. [PMID: 27217829 DOI: 10.7150/thno.14855] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 9.0] [Reference Citation Analysis]
3 Shcharbin D, Shcharbina N, Milowska K, de la Mata FJ, Muñoz-fernandez MA, Mignani S, Gomez-ramirez R, Majoral J, Bryszewska M. Interference of cationic polymeric nanoparticles with clinical chemistry tests—Clinical relevance. International Journal of Pharmaceutics 2014;473:599-606. [DOI: 10.1016/j.ijpharm.2014.07.054] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
4 Huang J, Wu F, Yu Y, Huang H, Zhang S, You J. Lipoic acid based core cross-linked micelles for multivalent platforms: design, synthesis and application in bio-imaging and drug delivery. Org Biomol Chem 2017;15:4798-802. [DOI: 10.1039/c7ob00927e] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 El Brahmi N, Mignani SM, Caron J, El Kazzouli S, Bousmina MM, Caminade AM, Cresteil T, Majoral JP. Investigations on dendrimer space reveal solid and liquid tumor growth-inhibition by original phosphorus-based dendrimers and the corresponding monomers and dendrons with ethacrynic acid motifs. Nanoscale 2015;7:3915-22. [PMID: 25503793 DOI: 10.1039/c4nr05983b] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
6 Mignani S, Shi X, Guidolin K, Zheng G, Karpus A, Majoral JP. Clinical diagonal translation of nanoparticles: Case studies in dendrimer nanomedicine. J Control Release 2021;337:356-70. [PMID: 34311026 DOI: 10.1016/j.jconrel.2021.07.036] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Sorokina SA, Shifrina ZB. Dendrimers as Antiamyloid Agents. Pharmaceutics 2022;14:760. [DOI: 10.3390/pharmaceutics14040760] [Reference Citation Analysis]
8 Liu Y, Pang Y, Toh MR, Chiu GN. Dual-functionalized poly(amidoamine) dendrimers with poly(ethylene glycol) conjugation and thiolation improved blood compatibility. J Pharm Pharmacol 2015;67:1492-502. [PMID: 26303576 DOI: 10.1111/jphp.12457] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
9 Shcharbin D, Bryszewska M, Mignani S, Shi X, Majoral JP. Phosphorus dendrimers as powerful nanoplatforms for drug delivery, as fluorescent probes and for liposome interaction studies: A concise overview. Eur J Med Chem 2020;208:112788. [PMID: 32883637 DOI: 10.1016/j.ejmech.2020.112788] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Markowicz-piasecka M, Mikiciuk-olasik E. Dendrimers in drug delivery. Nanobiomaterials in Drug Delivery. Elsevier; 2016. pp. 39-74. [DOI: 10.1016/b978-0-323-42866-8.00002-2] [Cited by in Crossref: 7] [Article Influence: 1.2] [Reference Citation Analysis]
11 Dong H, Han L, Wang J, Xie J, Gao Y, Xie F, Jia L. In vivo inhibition of circulating tumor cells by two apoptosis-promoting circular aptamers with enhanced specificity. J Control Release 2018;280:99-112. [PMID: 29746957 DOI: 10.1016/j.jconrel.2018.05.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
12 Pandit A, Zeugolis DI. Structured substrates and delivery vehicles: trending now in biomedicine. Nanomedicine (Lond) 2016;11:1489-93. [PMID: 27353654 DOI: 10.2217/nnm.16.47] [Cited by in Crossref: 5] [Article Influence: 0.8] [Reference Citation Analysis]
13 Akhtar S, Al-Zaid B, El-Hashim AZ, Chandrasekhar B, Attur S, Benter IF. Impact of PAMAM delivery systems on signal transduction pathways in vivo: Modulation of ERK1/2 and p38 MAP kinase signaling in the normal and diabetic kidney. Int J Pharm 2016;514:353-63. [PMID: 27032566 DOI: 10.1016/j.ijpharm.2016.03.039] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
14 Dib N, Fernández L, Santo M, Otero L, Alustiza F, Liaudat AC, Bosch P, Lavaggi ML, Cerecetto H, González M. Formation of dendrimer-guest complexes as a strategy to increase the solubility of a phenazine N, N'-dioxide derivative with antitumor activity. Heliyon 2019;5:e01528. [PMID: 31049437 DOI: 10.1016/j.heliyon.2019.e01528] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
15 Białkowska K, Miłowska K, Michlewska S, Sokołowska P, Komorowski P, Lozano-Cruz T, Gomez-Ramirez R, de la Mata FJ, Bryszewska M. Interaction of Cationic Carbosilane Dendrimers and Their siRNA Complexes with MCF-7 Cells. Int J Mol Sci 2021;22:7097. [PMID: 34281151 DOI: 10.3390/ijms22137097] [Reference Citation Analysis]
16 Li G, Zhang Y, Tang W, Zheng J. Comprehensive investigation of in vitro hemocompatibility of surface modified polyamidoamine nanocarrier. CH 2020;74:267-79. [DOI: 10.3233/ch-190641] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Tariq I, Ali MY, Sohail MF, Amin MU, Ali S, Bukhari NI, Raza A, Pinnapireddy SR, Schäfer J, Bakowsky U. Lipodendriplexes mediated enhanced gene delivery: a cellular to pre-clinical investigation. Sci Rep 2020;10:21446. [PMID: 33293580 DOI: 10.1038/s41598-020-78123-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
18 Cui Y, Liang B, Wang L, Zhu L, Kang J, Sun H, Chen S. Enhanced biocompatibility of PAMAM dendrimers benefiting from tuning their surface charges. Materials Science and Engineering: C 2018;93:332-40. [DOI: 10.1016/j.msec.2018.07.070] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
19 Bukhari SZ, Zeth K, Iftikhar M, Rehman M, Usman Munir M, Khan WS, Ihsan A. Supramolecular lipid nanoparticles as delivery carriers for non-invasive cancer theranostics. Curr Res Pharmacol Drug Discov 2021;2:100067. [PMID: 34909685 DOI: 10.1016/j.crphar.2021.100067] [Reference Citation Analysis]
20 Mignani S, Bryszewska M, Klajnert-Maculewicz B, Zablocka M, Majoral JP. Advances in combination therapies based on nanoparticles for efficacious cancer treatment: an analytical report. Biomacromolecules 2015;16:1-27. [PMID: 25426779 DOI: 10.1021/bm501285t] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 9.3] [Reference Citation Analysis]
21 Posadas I, Monteagudo S, Ceña V. Nanoparticles for brain-specific drug and genetic material delivery, imaging and diagnosis. Nanomedicine (Lond) 2016;11:833-49. [PMID: 26980585 DOI: 10.2217/nnm.16.15] [Cited by in Crossref: 60] [Cited by in F6Publishing: 47] [Article Influence: 10.0] [Reference Citation Analysis]
22 Jain P, Pawar R, Pandey R, Madan J, Pawar S, Lakshmi P, Sudheesh M. In-vitro in-vivo correlation (IVIVC) in nanomedicine: Is protein corona the missing link? Biotechnology Advances 2017;35:889-904. [DOI: 10.1016/j.biotechadv.2017.08.003] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 11.0] [Reference Citation Analysis]
23 Magruder JT, Crawford TC, Lin YA, Zhang F, Grimm JC, Kannan RM, Kannan S, Sciortino CM. Selective Localization of a Novel Dendrimer Nanoparticle in Myocardial Ischemia-Reperfusion Injury. Ann Thorac Surg 2017;104:891-8. [PMID: 28366468 DOI: 10.1016/j.athoracsur.2016.12.051] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
24 Sharma N, Saifi MA, Singh SB, Godugu C. In vivo studies: toxicity and biodistribution of nanocarriers in organisms. Nanotoxicity. Elsevier; 2020. pp. 41-70. [DOI: 10.1016/b978-0-12-819943-5.00003-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Chis AA, Dobrea CM, Rus LL, Frum A, Morgovan C, Butuca A, Totan M, Juncan AM, Gligor FG, Arseniu AM. Dendrimers as Non-Viral Vectors in Gene-Directed Enzyme Prodrug Therapy. Molecules 2021;26:5976. [PMID: 34641519 DOI: 10.3390/molecules26195976] [Reference Citation Analysis]
26 Gutierrez-ulloa CE, Buyanova MY, Apartsin EK, Venyaminova AG, de la Mata FJ, Gómez R. Carbon Nanotubes Decorated with Cationic Carbosilane Dendrons and Their Hybrids with Nucleic Acids. ChemNanoMat 2018;4:220-30. [DOI: 10.1002/cnma.201700351] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Hegde N, Velingkar V, Prabhakar B. An Update on Design and Pharmacology of Dendritic Poly(l-lysine). Int J Pept Res Ther 2019;25:1539-62. [DOI: 10.1007/s10989-018-9798-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
28 Dzmitruk V, Apartsin E, Ihnatsyeu-Kachan A, Abashkin V, Shcharbin D, Bryszewska M. Dendrimers Show Promise for siRNA and microRNA Therapeutics. Pharmaceutics 2018;10:E126. [PMID: 30096839 DOI: 10.3390/pharmaceutics10030126] [Cited by in Crossref: 38] [Cited by in F6Publishing: 26] [Article Influence: 9.5] [Reference Citation Analysis]
29 Akhtar S, El-hashim AZ, Chandrasekhar B, Attur S, Benter IF. Naked Polyamidoamine Polymers Intrinsically Inhibit Angiotensin II-Mediated EGFR and ErbB2 Transactivation in a Dendrimer Generation- and Surface Chemistry-Dependent Manner. Mol Pharmaceutics 2016;13:1575-86. [DOI: 10.1021/acs.molpharmaceut.6b00045] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
30 Yang L, Chen S, Shang T, Zhao R, Yuan B, Zhu X, Raucci MG, Yang X, Zhang X, Santin M, Ambrosio L. Complexation of Injectable Biphasic Calcium Phosphate with Phosphoserine-Presenting Dendrons with Enhanced Osteoregenerative Properties. ACS Appl Mater Interfaces 2020;12:37873-84. [PMID: 32687309 DOI: 10.1021/acsami.0c09004] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Kannan RM, Nance E, Kannan S, Tomalia DA. Emerging concepts in dendrimer-based nanomedicine: from design principles to clinical applications. J Intern Med 2014;276:579-617. [PMID: 24995512 DOI: 10.1111/joim.12280] [Cited by in Crossref: 301] [Cited by in F6Publishing: 267] [Article Influence: 37.6] [Reference Citation Analysis]
32 Bugno J, Hsu HJ, Hong S. Recent advances in targeted drug delivery approaches using dendritic polymers. Biomater Sci 2015;3:1025-34. [PMID: 26221937 DOI: 10.1039/c4bm00351a] [Cited by in Crossref: 31] [Cited by in F6Publishing: 11] [Article Influence: 3.9] [Reference Citation Analysis]
33 Leiro V, Duque Santos S, Lopes CDF, Paula Pêgo A. Dendrimers as Powerful Building Blocks in Central Nervous System Disease: Headed for Successful Nanomedicine. Adv Funct Mater 2018;28:1700313. [DOI: 10.1002/adfm.201700313] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
34 Zhang L, Hao P, Yang D, Feng S, Peng B, Appelhans D, Zhang T, Zan X. Designing nanoparticles with improved tumor penetration: surface properties from the molecular architecture viewpoint. J Mater Chem B 2019;7:953-64. [PMID: 32255100 DOI: 10.1039/c8tb03034k] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
35 Wu J, Liang H, Li Y, Shi Y, Bottini M, Chen Y, Liu L. Cationic Block Copolymer Nanoparticles with Tunable DNA Affinity for Treating Rheumatoid Arthritis. Adv Funct Mater 2020;30:2000391. [DOI: 10.1002/adfm.202000391] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
36 Ghosh S, Roy A, Singhania A, Chatterjee S, Swarnakar S, Fujita D, Bandyopadhyay A. In-vivo & in-vitro toxicity test of molecularly engineered PCMS: A potential drug for wireless remote controlled treatment. Toxicol Rep 2018;5:1044-52. [PMID: 30406021 DOI: 10.1016/j.toxrep.2018.10.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
37 Lesniak WG, Oskolkov N, Song X, Lal B, Yang X, Pomper M, Laterra J, Nimmagadda S, McMahon MT. Salicylic Acid Conjugated Dendrimers Are a Tunable, High Performance CEST MRI NanoPlatform. Nano Lett 2016;16:2248-53. [PMID: 26910126 DOI: 10.1021/acs.nanolett.5b04517] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
38 Akhtar S, Al-Zaid B, El-Hashim AZ, Chandrasekhar B, Attur S, Yousif MH, Benter IF. Cationic Polyamidoamine Dendrimers as Modulators of EGFR Signaling In Vitro and In Vivo. PLoS One 2015;10:e0132215. [PMID: 26167903 DOI: 10.1371/journal.pone.0132215] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
39 Shcharbin D, Shcharbina N, Shakhbazau A, Mignani S, Majoral J, Bryszewska M. Phosphorus-containing nanoparticles: biomedical patents review. Expert Opinion on Therapeutic Patents 2015;25:539-48. [DOI: 10.1517/13543776.2015.1010512] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
40 Franiak-pietryga I, Ziemba B, Messmer B, Skowronska-krawczyk D. Dendrimers as Drug Nanocarriers: The Future of Gene Therapy and Targeted Therapies in Cancer. In: Simonescu CM, editor. Dendrimers - Fundamentals and Applications. InTech; 2018. [DOI: 10.5772/intechopen.75774] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
41 Smith ES, Porterfield JE, Kannan RM. Leveraging the interplay of nanotechnology and neuroscience: Designing new avenues for treating central nervous system disorders. Adv Drug Deliv Rev 2019;148:181-203. [PMID: 30844410 DOI: 10.1016/j.addr.2019.02.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
42 Wu Y, Xu G, Jin X, Zhu X. Supramolecular dendritic polymers for diagnostic and theranostic applications. Sci China Mater 2018;61:1444-53. [DOI: 10.1007/s40843-018-9252-y] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
43 Mignani S, Bryszewska M, Zablocka M, Klajnert-maculewicz B, Cladera J, Shcharbin D, Majoral J. Can dendrimer based nanoparticles fight neurodegenerative diseases? Current situation versus other established approaches. Progress in Polymer Science 2017;64:23-51. [DOI: 10.1016/j.progpolymsci.2016.09.006] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 6.8] [Reference Citation Analysis]
44 Tang Y, Han Y, Liu L, Shen W, Zhang H, Wang Y, Cui X, Wang Y, Liu G, Qi R. Protective effects and mechanisms of G5 PAMAM dendrimers against acute pancreatitis induced by caerulein in mice. Biomacromolecules. 2015;16:174-182. [PMID: 25479110 DOI: 10.1021/bm501390d] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
45 Miranda M, Silva L, Carvalho I, Amaral R, de Paula M, Swiech K, Bastos J, Paschoal J, Emery F, dos Reis R, Bentley M, Marcato P. Targeted uptake of folic acid-functionalized polymeric nanoparticles loading glycoalkaloidic extract in vitro and in vivo assays. Colloids and Surfaces B: Biointerfaces 2020;192:111106. [DOI: 10.1016/j.colsurfb.2020.111106] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
46 Farvadi F, Ghahremani MH, Hashemi F, Reza Hormozi-nezhad M, Raoufi M, Zanganeh S, Atyabi F, Dinarvand R, Mahmoudi M. Cell shape affects nanoparticle uptake and toxicity: An overlooked factor at the nanobio interfaces. Journal of Colloid and Interface Science 2018;531:245-52. [DOI: 10.1016/j.jcis.2018.07.013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
47 Markowicz-Piasecka M, Sadkowska A, Podsiedlik M, Mikiciuk-Olasik E, Sikora J. Generation 2 (G2) - Generation 4 (G4) PAMAM dendrimers disrupt key plasma coagulation parameters. Toxicol In Vitro 2019;59:87-99. [PMID: 30981695 DOI: 10.1016/j.tiv.2019.04.010] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
48 Janiszewska J, Posadas I, Játiva P, Bugaj-Zarebska M, Urbanczyk-Lipkowska Z, Ceña V. Second Generation Amphiphilic Poly-Lysine Dendrons Inhibit Glioblastoma Cell Proliferation without Toxicity for Neurons or Astrocytes. PLoS One 2016;11:e0165704. [PMID: 27832093 DOI: 10.1371/journal.pone.0165704] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
49 Li J, Liang H, Liu J, Wang Z. Poly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy. Int J Pharm 2018;546:215-25. [PMID: 29787895 DOI: 10.1016/j.ijpharm.2018.05.045] [Cited by in Crossref: 106] [Cited by in F6Publishing: 108] [Article Influence: 26.5] [Reference Citation Analysis]
50 Chis AA, Dobrea C, Morgovan C, Arseniu AM, Rus LL, Butuca A, Juncan AM, Totan M, Vonica-Tincu AL, Cormos G, Muntean AC, Muresan ML, Gligor FG, Frum A. Applications and Limitations of Dendrimers in Biomedicine. Molecules 2020;25:E3982. [PMID: 32882920 DOI: 10.3390/molecules25173982] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 11.5] [Reference Citation Analysis]
51 Franiak-pietryga I, Ziemba B, Sikorska H, Jander M, Appelhans D, Bryszewska M, Borowiec M. Neurotoxicity of poly(propylene imine) glycodendrimers. Drug and Chemical Toxicology. [DOI: 10.1080/01480545.2020.1843472] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
52 Kamaruzaman KA, Moyle PM, Toth I. Peptide-Based Multicomponent Oligonucleotide Delivery Systems: Optimisation of Poly-l-lysine Dendrons for Plasmid DNA Delivery. Int J Pept Res Ther 2017;23:119-34. [DOI: 10.1007/s10989-016-9545-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
53 Tarach P, Janaszewska A. Recent Advances in Preclinical Research Using PAMAM Dendrimers for Cancer Gene Therapy. Int J Mol Sci 2021;22:2912. [PMID: 33805602 DOI: 10.3390/ijms22062912] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
54 Winnicka K, Wroblewska M, Sosnowska K, Car H, Kasacka I. Evaluation of cationic polyamidoamine dendrimers' dermal toxicity in the rat skin model. Drug Des Devel Ther 2015;9:1367-77. [PMID: 25834395 DOI: 10.2147/DDDT.S78336] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 2.1] [Reference Citation Analysis]
55 Mignani S, Shi X, Rodrigues J, Tomas H, Karpus A, Majoral JP. First-in-class and best-in-class dendrimer nanoplatforms from concept to clinic: Lessons learned moving forward. Eur J Med Chem 2021;219:113456. [PMID: 33878563 DOI: 10.1016/j.ejmech.2021.113456] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
56 Yang J, Zhang Q, Chang H, Cheng Y. Surface-Engineered Dendrimers in Gene Delivery. Chem Rev 2015;115:5274-300. [DOI: 10.1021/cr500542t] [Cited by in Crossref: 264] [Cited by in F6Publishing: 224] [Article Influence: 37.7] [Reference Citation Analysis]
57 Kheraldine H, Rachid O, Habib AM, Al Moustafa AE, Benter IF, Akhtar S. Emerging innate biological properties of nano-drug delivery systems: A focus on PAMAM dendrimers and their clinical potential. Adv Drug Deliv Rev 2021;178:113908. [PMID: 34390777 DOI: 10.1016/j.addr.2021.113908] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
58 Ziemba B, Borowiec M, Franiak-Pietryga I. There and back again: a dendrimer's tale. Drug Chem Toxicol 2021;:1-16. [PMID: 33910437 DOI: 10.1080/01480545.2021.1915327] [Reference Citation Analysis]
59 Nance E, Zhang F, Mishra MK, Zhang Z, Kambhampati SP, Kannan RM, Kannan S. Nanoscale effects in dendrimer-mediated targeting of neuroinflammation. Biomaterials 2016;101:96-107. [PMID: 27267631 DOI: 10.1016/j.biomaterials.2016.05.044] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 11.0] [Reference Citation Analysis]
60 Liu C, Jiang K, Tai L, Liu Y, Wei G, Lu W, Pan W. Facile Noninvasive Retinal Gene Delivery Enabled by Penetratin. ACS Appl Mater Interfaces 2016;8:19256-67. [PMID: 27400087 DOI: 10.1021/acsami.6b04551] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
61 Wong PT, Tang S, Cannon J, Yang K, Harrison R, Ruge M, O’konek JJ, Choi SK. Shielded α-Nucleophile Nanoreactor for Topical Decontamination of Reactive Organophosphate. ACS Appl Mater Interfaces 2020;12:33500-15. [DOI: 10.1021/acsami.0c08946] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
62 Grillaud M, Ruiz de Garibay AP, Bianco A. Polycationic adamantane-based dendrons form nanorods in complex with plasmid DNA. RSC Adv 2016;6:42933-42. [DOI: 10.1039/c6ra01281g] [Cited by in Crossref: 7] [Article Influence: 1.2] [Reference Citation Analysis]
63 Shakhbazau A, Mishra M, Chu T, Brideau C, Cummins K, Tsutsui S, Shcharbin D, Majoral J, Mignani S, Blanchard-desce M, Bryszewska M, Yong VW, Stys PK, van Minnen J. Fluorescent Phosphorus Dendrimer as a Spectral Nanosensor for Macrophage Polarization and Fate Tracking in Spinal Cord Injury: Fluorescent Phosphorus Dendrimer as a Macrophage Tracer. Macromol Biosci 2015;15:1523-34. [DOI: 10.1002/mabi.201500150] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
64 Spyropoulos-Antonakakis N, Sarantopoulou E, Trohopoulos PN, Stefi AL, Kollia Z, Gavriil VE, Bourkoula A, Petrou PS, Kakabakos S, Semashko VV, Nizamutdinov AS, Cefalas AC. Selective aggregation of PAMAM dendrimer nanocarriers and PAMAM/ZnPc nanodrugs on human atheromatous carotid tissues: a photodynamic therapy for atherosclerosis. Nanoscale Res Lett 2015;10:210. [PMID: 25991914 DOI: 10.1186/s11671-015-0904-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
65 Serchenya T, Shcharbin D, Shyrochyna I, Sviridov O, Terekhova M, Dzmitruk V, Abashkin V, Apartsin E, Mignani S, Majoral J, Ionov M, Bryszewska M. Immunoreactivity changes of human serum albumin and alpha-1-microglobulin induced by their interaction with dendrimers. Colloids and Surfaces B: Biointerfaces 2019;179:226-32. [DOI: 10.1016/j.colsurfb.2019.03.065] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
66 Abashkin V, Pędziwiatr-Werbicka E, Gómez R, de la Mata FJ, Dzmitruk V, Shcharbin D, Bryszewska M. Prospects of Cationic Carbosilane Dendronized Gold Nanoparticles as Non-viral Vectors for Delivery of Anticancer siRNAs siBCL-xL and siMCL-1. Pharmaceutics 2021;13:1549. [PMID: 34683842 DOI: 10.3390/pharmaceutics13101549] [Reference Citation Analysis]
67 Ionov M, Lazniewska J, Dzmitruk V, Halets I, Loznikova S, Novopashina D, Apartsin E, Krasheninina O, Venyaminova A, Milowska K, Nowacka O, Gomez-Ramirez R, de la Mata FJ, Majoral JP, Shcharbin D, Bryszewska M. Anticancer siRNA cocktails as a novel tool to treat cancer cells. Part (A). Mechanisms of interaction. Int J Pharm 2015;485:261-9. [PMID: 25791760 DOI: 10.1016/j.ijpharm.2015.03.024] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
68 Choi SK. Nanomaterial-Enabled Sensors and Therapeutic Platforms for Reactive Organophosphates. Nanomaterials (Basel) 2021;11:224. [PMID: 33467113 DOI: 10.3390/nano11010224] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]